Anguilla Healthcare Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Anguilla Healthcare Digest.

Press releases published on August 7, 2026

Aug. 7, 2026

Nova Leap Health Corp. Posts Record Q2 2026 Revenue, Income from Operating Activities and Adjusted EBITDA

Indeterminate GlobeNewswire

Aug. 7, 2026

Citizens Commission on Human Rights International Urges U.S. Action After U.N. Committee Condemns Forced Psychiatric Detention and Treatment

Indeterminate GlobeNewswire

Aug. 7, 2026

SodaTide Capsule Label Guide: What the Supplement Facts Panel, Serving Directions, and Safety Statements Disclose for 2026

Indeterminate GlobeNewswire

Aug. 7, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 7, 2026

iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants

Indeterminate GlobeNewswire

Aug. 7, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

Aug. 7, 2026

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 7, 2026

Entera Announces Second Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

Aug. 7, 2026

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 7, 2026

Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Indeterminate GlobeNewswire

Aug. 7, 2026

Amwell makes grant to new employees under inducement plan

Indeterminate GlobeNewswire

Aug. 7, 2026

Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference

Indeterminate GlobeNewswire

Aug. 7, 2026

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 7, 2026

aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD

Indeterminate GlobeNewswire

Aug. 7, 2026

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 7, 2026

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans

Indeterminate GlobeNewswire

Aug. 7, 2026

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 7, 2026

PetVivo Sets Fiscal First Quarter 2027 Conference Call for Friday, August 14, 2026 at 5:00 p.m. ET

Indeterminate GlobeNewswire

Aug. 7, 2026

DirectMax Prescription Management Update Details Patient Support and Telehealth Access Through Direct Meds

Indeterminate GlobeNewswire

Aug. 7, 2026

U.S. Senate Passes DeOndra Dixon INCLUDE Project Act

Indeterminate GlobeNewswire